Reduction of Diabetic Foot Ulcer Healing Times Through Use of Advanced Treatment Modalities
Overview
Affiliations
Diabetic wounds are a major health care problem associated with delayed healing and high amputation rates. This review systematically evaluated newer wound care therapies for the treatment of diabetic wounds. More recent means of approaching diabetic foot ulcers include various dressings, off-loading shoes, and bioengineered skin constructs and growth factors. Electrical stimulation, phototherapy, electromagnetic fields, and shockwave therapy have been further proposed as potential treatments. A brief overview of these treatments is presented using peer-reviewed evidenced-based literature. A review of the literature demonstrated that treatment of diabetic wounds has focused on either prevention of the wounds in the form of off-loading shoes or adequate protective dressings or on direct treatment of wounds with bioengineered skin constructs, growth factors, or medical devices that accelerate wound healing. The authors' conclusion, following extensive literature review, is that although excellent national and international guidelines exist regarding suggested approaches to the treatment of the diabetic foot ulcer, there is no definitive or universal consensus on the choice of specific treatment modalities. The importance of optimizing comorbidities and the disease state, hemodynamics, local and peripheral skin and wound care, and metabolic challenges while reducing biological and bacterial burden and minimizing trauma remain the primary approach, followed by choice of the most appropriate treatment material or product.
Schmiedova I, Slama P, Dembickaja A, Kozova B, Hyneckova V, Gogolkova S BioTech (Basel). 2024; 13(3).
PMID: 39311338 PMC: 11417787. DOI: 10.3390/biotech13030036.
Widigdo D, Sofro Z, Pangastuti H, Dachlan I Curr Diabetes Rev. 2023; 20(8):1-11.
PMID: 37921159 DOI: 10.2174/0115733998229877230926073555.
Efficacy of 15% lysine cream in treating diabetic foot ulcers: a randomized interventional study.
Shashikumara S, Jayaraman V, Chikkegowda P, Lingaiah D, Kalal B Int J Physiol Pathophysiol Pharmacol. 2023; 15(3):88-97.
PMID: 37457650 PMC: 10349317.
Tang R, Zhao G, Wang Y, Zhang R IET Nanobiotechnol. 2022; 16(9):316-324.
PMID: 36161768 PMC: 9667746. DOI: 10.1049/nbt2.12099.
Protease-Triggered Release of Stabilized CXCL12 from Coated Scaffolds in an Ex Vivo Wound Model.
Spiller S, Wippold T, Bellmann-Sickert K, Franz S, Saalbach A, Anderegg U Pharmaceutics. 2021; 13(10).
PMID: 34683890 PMC: 8539926. DOI: 10.3390/pharmaceutics13101597.